The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2α and ATF4 in Lung Cancer

Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/act...

Full description

Saved in:
Bibliographic Details
Published inDisease markers Vol. 2018; no. 2018; pp. 1 - 9
Main Authors Hua, Chung-Ching, Kuo, Wei-Ke, Chen, Tzu-Ping, Chang, Liang-Che
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 01.01.2018
Hindawi
John Wiley & Sons, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. Materials and Methods. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. Results. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. Conclusion. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer.
AbstractList The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment.INTRODUCTIONThe expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment.The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot.MATERIALS AND METHODSThe protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot.The protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues.RESULTSThe protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues.The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer.CONCLUSIONThe PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer.
Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2 α )/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFN α . The eIF2 α /ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. Materials and Methods. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2 α , and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. Results. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2 α , and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2 α , and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. Conclusion. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer.
Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. Materials and Methods. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. Results. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. Conclusion. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer.
The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2 )/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFN . The eIF2 /ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2 , and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2 , and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2 , and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer.
Author Kuo, Wei-Ke
Chen, Tzu-Ping
Chang, Liang-Che
Hua, Chung-Ching
AuthorAffiliation 3 Division of Pulmonary, Critical Care and Sleep Medicine, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan
2 Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan
1 Department of Pathology, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan
AuthorAffiliation_xml – name: 2 Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan
– name: 3 Division of Pulmonary, Critical Care and Sleep Medicine, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan
– name: 1 Department of Pathology, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan
Author_xml – sequence: 1
  fullname: Hua, Chung-Ching
– sequence: 2
  fullname: Kuo, Wei-Ke
– sequence: 3
  fullname: Chen, Tzu-Ping
– sequence: 4
  fullname: Chang, Liang-Che
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30305853$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFuEzEQhi1URNPCjTOyxAWphHrW9q73glSlDY0UiR7C2Tje2ayrjR3sDaWPxYvwTDhKKFAJcfEc_M0__8x_Qo588EjIS2DvAKQ8Lxioc8lKVTF4QkagKjlWJWdHZMSKSo1ZIdgxOUnpljEoalE_I8eccSaV5CPyedEhvYlhQOfp1bdNxJRc8DS09OZyDnSW6LVbdf09nYQYsTcDNvTODR1ddCHhjsPZtPjxnRrf0IvFVNAsNN_6FZ0YbzE-J09b0yd8cain5NP0ajG5Hs8_fphNLuZjKyoY8otVjXLZNNAuWw5M1UwYUMCxbU1lkGGDwljFa7W0AtBaKWxT10VZMlQNPyXv97qb7XKNjUU_RNPrTXRrE-91ME7__eNdp1fhqy6hlFKpLPDmIBDDly2mQa9dstj3xmPYJl0AKA4ABWT09SP0Nmyjz-vtKFFC9s4y9epPRw9Wfh0_A2_3gI0hpYjtAwJM77LVu2z1IduMF49w6wYz5LTyPq7_V9PZvqlzvjF37n8jDpYxM9ia3zRILpjkPwFqw7vk
CitedBy_id crossref_primary_10_3389_fphar_2021_670900
crossref_primary_10_1016_j_heliyon_2024_e37376
crossref_primary_10_5812_jai_141895
crossref_primary_10_1089_jir_2024_0242
crossref_primary_10_1038_s41598_022_08356_0
crossref_primary_10_1080_1354750X_2022_2102211
crossref_primary_10_1016_j_jbc_2022_101930
crossref_primary_10_1631_jzus_B2200195
crossref_primary_10_3390_ijms20112654
crossref_primary_10_1186_s13046_021_01987_7
crossref_primary_10_1007_s00262_024_03666_w
crossref_primary_10_3233_CBM_190828
crossref_primary_10_3389_fonc_2021_734853
crossref_primary_10_1080_2162402X_2021_1962591
Cites_doi 10.1056/NEJMoa1507643
10.1016/j.celrep.2017.04.031
10.1158/1078-0432.CCR-15-1714
10.1038/nature01322
10.1016/j.trecan.2017.11.005
10.1158/1078-0432.CCR-10-1114
10.1038/nrc3239
10.1038/nrm2199
10.1038/sj.cdd.4401373
10.1080/10635150290069913
10.1016/j.immuni.2006.08.009
10.4049/jimmunol.1002240
10.1038/nri3581
10.1016/j.ceb.2017.05.007
10.1056/NEJMoa1504627
10.1038/ni.2762
10.18632/oncotarget.1542
10.1158/1538-7445.AM2017-1704
10.1158/2159-8290.CD-17-0226
10.1128/MCB.14.2.1500
10.1056/NEJMoa1606774
10.1126/scitranslmed.aad7118
10.1146/annurev.immunol.26.021607.090331
10.1126/science.aab4082
10.1038/nature03464
10.1007/s00262-009-0804-6
10.1093/annonc/mdv615
10.1101/cshperspect.a027086
10.1038/gene.2011.21
10.1016/j.ejca.2017.01.011
10.1038/ni1443
10.1016/S0140-6736(15)01281-7
10.18632/oncotarget.7582
10.1038/bjc.1998.528
10.1056/NEJMra1703481
10.1158/1535-7163.MCT-17-0386
10.4161/jkst.27521
10.1016/j.cell.2016.12.004
10.1038/s41388-018-0125-3
10.1007/s10555-016-9652-y
ContentType Journal Article
Copyright Copyright © 2018 Liang-Che Chang et al.
Copyright © 2018 Liang-Che Chang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0
Copyright © 2018 Liang-Che Chang et al. 2018
Copyright_xml – notice: Copyright © 2018 Liang-Che Chang et al.
– notice: Copyright © 2018 Liang-Che Chang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2018 Liang-Che Chang et al. 2018
DBID ADJCN
AHFXO
RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7TK
8FD
C1K
FR3
P64
RC3
7X8
5PM
DOI 10.1155/2018/5068701
DatabaseName الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Biotechnology Research Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef


Genetics Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1875-8630
Editor Gazzaniga, Paola
Editor_xml – sequence: 1
  givenname: Paola
  surname: Gazzaniga
  fullname: Gazzaniga, Paola
EndPage 9
ExternalDocumentID PMC6165588
30305853
10_1155_2018_5068701
1153405
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: Chang Gung Memorial Hospital, Linkou
  grantid: CMRPG2F0521
GroupedDBID ---
.GJ
0R~
24P
29G
36B
4.4
53G
5GY
5RE
5VS
AAFNC
AAFWJ
AAJEY
ABDBF
ABJNI
ABUBZ
ACGFS
ACIWK
ACPQW
ACPRK
ADBBV
ADJCN
ADRAZ
ADZMO
AENEX
AFRAH
AFRHK
AGIAB
AHFXO
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CAG
COF
DIK
DU5
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
GROUPED_DOAJ
H13
HYE
HZ~
IAO
IHR
IL9
INH
INR
IOS
IPNFZ
KQ8
M48
MET
MIO
O9-
OK1
P2P
RHX
RIG
RNS
RPM
SV3
TUS
ZGI
ITC
RHU
RHW
AAYXX
ACCMX
CITATION
ACUHS
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7TK
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c471t-c4e79e5bdd1fbf3108904a1813effa7ae0ede4ac8398bc41ecc54cd992660e8d3
IEDL.DBID M48
ISSN 0278-0240
1875-8630
IngestDate Thu Aug 21 13:50:46 EDT 2025
Fri Jul 11 08:44:26 EDT 2025
Fri Jul 25 09:30:12 EDT 2025
Wed Feb 19 02:34:21 EST 2025
Tue Jul 01 04:22:15 EDT 2025
Thu Apr 24 22:59:40 EDT 2025
Sun Jun 02 18:54:07 EDT 2024
Tue Nov 26 16:44:34 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2018
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c471t-c4e79e5bdd1fbf3108904a1813effa7ae0ede4ac8398bc41ecc54cd992660e8d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Paola Gazzaniga
ORCID 0000-0002-2902-751X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2018/5068701
PMID 30305853
PQID 2114619040
PQPubID 2046413
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6165588
proquest_miscellaneous_2118311121
proquest_journals_2114619040
pubmed_primary_30305853
crossref_primary_10_1155_2018_5068701
crossref_citationtrail_10_1155_2018_5068701
hindawi_primary_10_1155_2018_5068701
emarefa_primary_1153405
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: United States
– name: Amsterdam
PublicationTitle Disease markers
PublicationTitleAlternate Dis Markers
PublicationYear 2018
Publisher Hindawi Publishing Corporation
Hindawi
John Wiley & Sons, Inc
Publisher_xml – name: Hindawi Publishing Corporation
– name: Hindawi
– name: John Wiley & Sons, Inc
References 22
24
25
26
27
28
29
30
31
10
32
11
33
12
34
13
35
14
36
15
37
16
38
17
39
18
19
1
2
3
4
5
6
7
8
9
40
41
20
21
(23) 2017
References_xml – ident: 5
  doi: 10.1056/NEJMoa1507643
– ident: 28
  doi: 10.1016/j.celrep.2017.04.031
– ident: 22
  doi: 10.1158/1078-0432.CCR-15-1714
– ident: 10
  doi: 10.1038/nature01322
– ident: 27
  doi: 10.1016/j.trecan.2017.11.005
– ident: 40
  doi: 10.1158/1078-0432.CCR-10-1114
– ident: 9
  doi: 10.1038/nrc3239
– year: 2017
  ident: 23
– ident: 17
  doi: 10.1038/nrm2199
– ident: 31
  doi: 10.1038/sj.cdd.4401373
– ident: 24
  doi: 10.1080/10635150290069913
– ident: 35
  doi: 10.1016/j.immuni.2006.08.009
– ident: 18
  doi: 10.4049/jimmunol.1002240
– ident: 11
  doi: 10.1038/nri3581
– ident: 33
  doi: 10.1016/j.ceb.2017.05.007
– ident: 4
  doi: 10.1056/NEJMoa1504627
– ident: 12
  doi: 10.1038/ni.2762
– ident: 37
  doi: 10.18632/oncotarget.1542
– ident: 16
  doi: 10.1158/1538-7445.AM2017-1704
– ident: 15
  doi: 10.1158/2159-8290.CD-17-0226
– ident: 39
  doi: 10.1128/MCB.14.2.1500
– ident: 2
  doi: 10.1056/NEJMoa1606774
– ident: 26
  doi: 10.1126/scitranslmed.aad7118
– ident: 25
  doi: 10.1146/annurev.immunol.26.021607.090331
– ident: 34
  doi: 10.1126/science.aab4082
– ident: 19
  doi: 10.1038/nature03464
– ident: 29
  doi: 10.1007/s00262-009-0804-6
– ident: 7
  doi: 10.1093/annonc/mdv615
– ident: 13
  doi: 10.1101/cshperspect.a027086
– ident: 36
  doi: 10.1038/gene.2011.21
– ident: 41
  doi: 10.1016/j.ejca.2017.01.011
– ident: 8
  doi: 10.1038/ni1443
– ident: 3
  doi: 10.1016/S0140-6736(15)01281-7
– ident: 6
  doi: 10.18632/oncotarget.7582
– ident: 30
  doi: 10.1038/bjc.1998.528
– ident: 1
  doi: 10.1056/NEJMra1703481
– ident: 14
  doi: 10.1158/1535-7163.MCT-17-0386
– ident: 20
  doi: 10.4161/jkst.27521
– ident: 32
  doi: 10.1016/j.cell.2016.12.004
– ident: 38
  doi: 10.1038/s41388-018-0125-3
– ident: 21
  doi: 10.1007/s10555-016-9652-y
SSID ssj0012949
Score 2.2505758
Snippet Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and...
Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and...
The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of...
SourceID pubmedcentral
proquest
pubmed
crossref
hindawi
emarefa
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Activating transcription factor 4
Activating Transcription Factor 4 - genetics
Activating Transcription Factor 4 - metabolism
Adenocarcinoma
Apoptosis
B7-H1 Antigen - genetics
B7-H1 Antigen - metabolism
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Cancer
Cancer therapies
Carcinoma - genetics
Carcinoma - metabolism
Cellular stress response
Correlation
Endoplasmic reticulum
Eukaryotic Initiation Factor-2 - genetics
Eukaryotic Initiation Factor-2 - metabolism
Genes
Humans
Immune system
Immunoglobulins
Initiation factor eIF-2
Interferon
Interferon regulatory factor 1
Interferon regulatory factor 7
Lung cancer
Lung Neoplasms - genetics
Lung Neoplasms - metabolism
Lymphocytes
Mutation
PD-1 protein
Protein expression
Protein folding
Proteins
Squamous cell carcinoma
STAT Transcription Factors - genetics
STAT Transcription Factors - metabolism
Stat1 protein
Stat2 protein
Subgroups
Tissues
Transcription factors
Tumors
SummonAdditionalLinks – databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3bjtMwELWg0iJe0HLdsGVlpPKEKuLEbuPHqrRqUUF9aKW-BceeqJW66aoXwX7W_gjfxEzjBlpYwUsuysSJcmyfM_ZkzFhDRVqAs7YpHLYmGeeAbU7qZq61AguKnGiKtvjSGkzlp5ma-SRJmz-n8JHt0D0XyQcVtrBmoZvzEHfklA9m1WRBpEuVG1GyWGSoQ3z7yb1HzHMG1wYPkI7O5uT8flv8TWKeRkr-Rj39c_bEa0beKUF-yh5A8Yw9-uxnxZ-zr4g1H1PChUXBe999aGvBVzkffxwJPtxwCudY3vIurcWxRHnpOA3A8sl8tQGyg2E_-nHHTeF4Z9KXHAsaYTfAu1Qp1i_YtN-bdAdNv3JC0yLZbHELbQ0qc07kWY4KLtGhNEjmMeS5aRsIwYE0FtVRklkpEEclrdMa6TqExMUvWa1YFXDBuDBtaU2kjQBKPRcbVHyZEMYZLFDkKmDvD181tT6tOK1usUz37oVSKWGQegwC9q6yvinTadxj98oD9MsM-2ZUlwFreMD-UUD9gGbqW-UmjegXbFRAMgzY2-oytieaJDEFrHZ7myRGAojoHUrwqwfF1DuivglY-6haVAaUq_v4SrGY73N2t0RLqSR5_X9vf8ke02k51FNnte16B29Q_Gyzq33V_wmT7vlp
  priority: 102
  providerName: Hindawi Publishing
Title The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2α and ATF4 in Lung Cancer
URI https://search.emarefa.net/detail/BIM-1153405
https://dx.doi.org/10.1155/2018/5068701
https://www.ncbi.nlm.nih.gov/pubmed/30305853
https://www.proquest.com/docview/2114619040
https://www.proquest.com/docview/2118311121
https://pubmed.ncbi.nlm.nih.gov/PMC6165588
Volume 2018
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEB2VolZ9QVyLoa0WqTyhgNfejb0PCFVpoxRaVFAi5c2svWMlUnAgSUX7WfxIv6kzvqSkKkLixbLk8foyMz5ndsczAPs6MBJdlrWkI29SYY7kc8q0cmM0Zqg5iOZsi8_t3kB9HOrhGjTdRusXOL8ztON-UoPZ5O3Fz8sP5PDvS4fXmuJ3Gb_TfptMj-Kg-4RJEfcyOFU36wmBqYhwwPVkCcSaFPhbZ2_BZsgeEOtwBac28LulHQKvjRGHyr_GdxHS23mVfwBV9yE8qBmmOKhM4hGsYfEYNk_rNfQn8I0sQ5xxeYZxIY4u6kTYQkxzcXZ4IsXxXHDyx-RSdLhzx4TIqBM8XSv6o-kcWQ6Pu8HVb2ELJw76XSVooBP6aIgOm9DsKQy6R_1Or1X3WWhlBE0L2mJkUKfOyTzNie_FxleWoD_EPLeRRR8dKpsRl4rTTEnSulaZM4bA3cfYhc9gvZgW-ByEtJHKbGCsRC5UF1rih6mU1lkaUObagzfNW02yugg598KYJGUwonXC6khqdXjwein9oyq-8Re57VpBN2L0JScu6sF-rbB_DLDTaDNpTDAJ-Idt4kvK9-DV8jB5Hy-p2AKn56VMHBJcBHwPlfKXF2osyYNoxSyWAlzZe_VIMR6VFb7bsq11HL_47zNfwhY_XzVXtAPri9k57hJ7WqR7cO_Tl3ivdA_afu0NrwGuKBTW
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Protein+Expression+of+PDL1+Is+Highly+Correlated+with+Those+of+eIF2%CE%B1+and+ATF4+in+Lung+Cancer&rft.jtitle=Disease+markers&rft.au=Chang%2C+Liang-Che&rft.au=Chen%2C+Tzu-Ping&rft.au=Kuo%2C+Wei-Ke&rft.au=Hua%2C+Chung-Ching&rft.date=2018-01-01&rft.pub=Hindawi&rft.issn=0278-0240&rft.eissn=1875-8630&rft.volume=2018&rft_id=info:doi/10.1155%2F2018%2F5068701&rft_id=info%3Apmid%2F30305853&rft.externalDocID=PMC6165588
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-0240&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-0240&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-0240&client=summon